News

OCSRI’s Dr. Caleb Scheckel Receives Prestigious 40 Under 40 in Cancer Award

OCSRI is thrilled to announce that Dr. Caleb J. Scheckel has been selected as a recipient of the prestigious 40 Under 40 in Cancer Award…. Read more

OCSRI is thrilled to announce that Dr. Caleb J. Scheckel has been selected as a recipient of the prestigious 40 Under 40 in Cancer Award.

Dr. Caleb J. Scheckel is the only Oklahoman physician to earn this national award for his outstanding work in cancer treatment as an emerging leader in the field.

Oklahoma Cancer Specialists and Research Institute is proud to announce Hematologist Caleb J. Scheckel, DO has been selected to receive this year’s esteemed 40 Under 40 in Cancer award. This significant honor, selected by a national panel of oncology judges, recognizes the contributions of emerging leaders under 40 and the strides they are making in the fight against cancer. Dr. Scheckel is the only physician in Oklahoma to receive the award.

“I am deeply honored and humbled to receive this award,” Dr. Scheckel said. “It reflects not just personal efforts, but also the support and collaboration of my colleagues at OCSRI. We are united in our mission to provide the best possible care to our patients, and this distinction is a testament to our collective dedication.”

Dr. Scheckel’s recognition among this group showcases the high-quality cancer treatment options at OCSRI. As the only recipient of this year’s award in Oklahoma, Dr. Scheckel exemplifies the medical expertise patients can expect at OCSRI. His achievements spotlight the institute’s commitment to both innovation in cancer treatment and the patients it serves.

“Dr. Scheckel’s 40 Under 40 in Cancer award is a well-deserved honor,” says OCSRI President and Gynecologic Oncologist Dr. Daron Street. “His dedication to patient care and innovative research embody the core values that drive our institute. We are proud to have him as a member of our team and congratulate him on this accomplishment.”

Dr. Scheckel is a Tulsa native who serves OCSRI’s main Tulsa facility. His passion for clinical trials and development sets him apart and drives his success in studying cancerous and non-cancerous blood conditions. His other research interests focus on quality improvement, safety, healthcare policy and medical economics. OCSRI’s unwavering dedication to both patients and caregivers, paired with exemplary medical skills, allows world-class physicians like Dr. Scheckel to best advocate for patients in their journey to recovery. For more information, please visit ocsri.org

Dr. Scheckel’s commitment, expertise, and compassion exemplify the spirit of this award, and we’re proud to have him as part of our team at OCSRI. Join us in celebrating this well-deserved achievement and thanking him for his dedication to advancing cancer care!

About Dr. Scheckel

Dr. Scheckel received a bachelor’s degree in finance and a medical degree from Oklahoma State University. He completed a residency in internal medicine at Mayo Clinic Arizona and a fellowship in hematology and medical oncology at Mayo Clinic Minnesota. He concurrently completed a fellowship in healthcare policy from the American Osteopathic Association. Dr. Scheckel has a passion for clinical trial development and has partnered with pharmaceutical companies developing novel applications of established therapies.